Year: 2020
Type: review
Abstract: )-β-caryophyllene (BCP) is a bicyclic sesquiterpene widely distributed in the plant kingdom, where it contributes a unique aroma to essential oils and has a pivotal role in the survival and evolution of higher plants. Recent studies provided evidence for protective roles of BCP in animal cells, highlighting its possible use as a novel therapeutic tool. Experimental results show the ability of BCP to reduce pro-inflammatory mediators such as tumor necrosis factor-alfa (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), thus ameliorating chronic pathologies characterized by inflammation and oxidative stress, in particular metabolic and neurological diseases. Through the binding to CB2 cannabinoid receptors and the interaction with members of the family of peroxisome proliferator-activated receptors (PPARs), BCP shows beneficial effects on obesity, non-alcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) liver diseases, diabetes, cardiovascular diseases, pain and other nervous system disorders. This review describes the current knowledge on the biosynthesis and natural sources of BCP, and reviews its role and mechanisms of action in different inflammation-related metabolic and neurologic disorders.
Source: Nutrients
DOI: 10.3390/nu12113273
Institution: University of Turin
Language: English
Subfield: Organic Chemistry
Field: Chemistry
Domain: Physical Sciences
Keywords: (E)-caryophyllene, sesquiterpenes, chronic inflammation, anti-inflammatory activity, oxidative stress, CB2 receptor, peroxisome proliferator-activated receptors, NF-κB signaling, TNF-α, interleukins, obesity, non-alcoholic fatty liver disease, diabetes mellitus, cardiovascular disease, pain, neurological disorders, biosynthesis, natural sources
Open Access status: gold
Estimated APC paid: $2,112
Funder: Università degli Studi di Torino
OpenAlex ID: W3096485642
